AllDocs -> cancers

Web Immagini Gruppi Directory News Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:4jZjNW-RrG8J:www.annalsmed.org/pdfSep01/golka.pdf allintitle: bladder cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ©2004 ...

l del file contenuto in http://www.medicine.mcgill.ca/epidemiology/platt/681/Ex22002.doc . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:gy9RKak7L0EJ:www.medicine.mcgill.ca/epidemiology/platt/681/Ex22002.doc+allintitle:+bladder+cancer+filetype:pdf+OR++filetype:doc+OR+filetype:ppt+OR++filetype:xls+OR+filetype:rtf&hl=it&lr=lang_en Google non è collegato agli autori di questa pagina e non è responsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: allintitle bladder cancer 513-681C Homework 2 Due: May 7, 2002 Download the dataset lowbwt_dat.txt and the description file lowbwt.txt from the course web site. These data are a ...

bladder cancer BLADDER CANCER SURVIVORS Vincent Sussman I am a Bladder cancer survivorSeveral weeks before my 80th birthday, a grade 4 cancer was discovered in the muscle lining of my bladder . My bladder had to be removed and a piece of my intestine would be used to conduct the urine through my abdominal skin into a plastic pouch. ...

Web Immagini Gruppi Directory News Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:056MMYj3kaQJ:www.immucyst.com/files/stckholm/eur7a000.pdf allintitle: bladder cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

Dr Willem Oosterlinck is currently Chairman of the Superficial Bladder Cancer Committee of the European Organisation for Research and Treatment of Cancer (EORTC) and heads the Department of Urology at the University Hospital Ghent in Belgium. Formerly President of the Belgian Society of Urology (BVU) and the Belgian Congress of Urology, he is currently a member of the Accreditation Commission for Urology of the Ministry of Health, the European Urological Association (EAU), The Société Internationale d’Urologie (SIU) and BVU. Dr Oosterlinck was also Chairman of the committee responsible for development of guidelines on superficial bladder tumours in the EAU. He began his career at the University Hospital Ghent as a Senior Assistant in Urology and advanced to Adjunct Director of the Department of Urology, prior to earning his current position. ...

ANNIVERSARY ISSUE Current concepts in assessment and treatment of bladder cancer Waleed Hassen and Michael J. Droller Transitional cell carcinoma of the bladder is comprised of a variety of cancer diatheses that manifest a spectrum of distinct biologic potentials. The challenge is to control superficial disease recurrence and progression and to identify invasive carcinoma at an earlier stage, when it may be more amenable to cure. Curr Opin Urol 10:291±299. # 2000 Lippincott Williams & Wilkins. Department of Urology, The Mount Sinai Medical Center, New York, New York, USA Correspondence to Waleed Hassen, The Mount Sinai Medical Center, One Gustave L. Levy Place, Department of Urology, Box 1272, New York, NY 10029-6574, USA Tel: +1 212 241 8711; fax: +1 212 876 3246 Current Opinion in Urology 2000, 10:291±299 Abbreviations BCG bacille Calmette±GueÂrin ...

Bladder Cancer Overview: About 55,000 individuals are diagnosed with bladder cancer in the United States each year and about 10,000 deaths are reported for the condition. Bladder cancer is most common among individuals over age 50; the condition is three times more common in men than in women. Smoking has been indicated as a major risk factor, as is exposure to chemicals in certain industrial applications. The disease is also common with frequent visitors to the tropics where the parasitic infec- tion with schistosomiasis is prevalent. The most common type of bladder cancer is transitional cell carcinoma, representing roughly 90% of all bladder cancers. These cancers arise from the epithelial cells that line the bladder . Other types of bladder cancer include papillary, squamous cell carcinoma, and adenocarcinoma, which have a poorer diagnosis and are rated higher. Bladder ...

abstracted & translated by Honora Lee Wolfe , Dipl. Ac., Lic. Ac., FNAAOM K e y w o r d s : Chinese medicine, acupuncture, warm needle, post cervical cancer radical sur- gery bladder numbness Radical hysterectomy for cervical cancer can damage the nerves associated with the bladder . Therefore, there can be post-operative bladder numbness and urinary retention. Xie Ying pub- lished an article titled, “A Clinical Audit of the Treatment of 136 Cases of Post Cervical Cancer Radical Surgery Bladder Numbness with Warm Needle Moxibustion,” in issue #4, 2002 of Zhong Yi Za Zhi (Journal of Chinese Medicine) on page 267. A precis of this article appears below. Cohort description: One hundred thirty-six women with post-opera- tive cervical cancer bladder numbness were divided into three groups. The treatment group ...

Entering the unresolved debate between alcohol consumption and bladder cancer , epidemiologists analysed data from an Italian case-control study and concluded that even in populations that drink a lot (in this case, wine) there is no significant associ- ation between the two. It’s possible that con- founding factors such as smoking, coffee drinking, and occupation (allowed for in this analysis) may have given rise to earlier inconsistent results ( Journal of Clinical Epi- demiology 2002;55:637-41). Summer sunburn seems to be the norm among American teenagers despite high sunscreen use. With 72% of teenagers ex- periencing at least one sunburn during the summer, public health campaigns should probably be paying more attention to getting the message across about hat wearing, protective clothing, and avoiding peak exposure times in the war against skin cancer ...

Immunotherapy for Bladder Cancer Ashish M. Kamat, MD and Donald L. Lamm, MD Address Department of Urology, PO Box 9251, Health Sciences Center, West Virginia University, Morgantown, WV 26506, USA. E-mail: dlamm@hsc.wvu.edu Current Urology Reports 2001, 2 :62 –69 Current Science Inc. ISSN 1527–2737 Copyright © 2001 Current Science Inc. Introduction The initial treatment for transitional cell carcinoma (TCC) of the bladder is transurethral resection, an essential step in immunotherapy because a low tumor burden increases the chances of therapeutic success. Intravesical therapy can then be used to treat residual tumor or carcinoma in situ, to prevent recurrences of the tumor, and to prevent progression of disease. Superficial TCC tumors are those that have not invaded the muscularis propria and include papillary lesions confined to the urothelium above ...

Arsenic in Drinking Water and Bladder Cancer Mortality in the United States: An Analysis Based on 133 U.S. Counties and 30 Years of Observation Steven H. Lamm, MD Arnold Engel, MD Michael B. Kruse, PhD Manning Feinleib, MD Daniel M. Byrd, PhD Shenghan Lai, PhD Richard Wilson, DPhil This study analyzes the relationship between arsenic exposure through drinking water and bladder cancer mortality. The county-specific white male bladder cancer mortality data (1950 –1979) and county-specific groundwater arsenic concentration data were obtained for 133 U.S. counties known to be exclusively dependent on groundwater for their public drinking water supply. No arsenic-related increase in bladder cancer mortality was found over the exposure range of 3 to 60 g/L using stratified analysis and regression analyses (both unweighted ...

MARCH 2004 European Association of Urology GUIDELINES ON BLADDER CANCER MUSCLE-INVASIVE AND METASTATIC G. Jakse, F. Algaba, S. Fossa, A. Stenzl, C. Sternberg Page 2 TABLE OF CONTENTS PAGE 1 INTRODUCTION 4 2 CLASSIFICATION 4 2.1 TNM staging 4 2.2 Histological grading 4 2.3 References 5 3 RISK FACTORS 5 4 DIAGNOSIS 5 4.1 Symptoms 5 4.2 Physical examination 5 4.3 Cystoscopy and TUR 5 4.4 References 5 5 STAGING 6 5.1 T-staging 6 5.1.1 TUR and bimanual palpation 6 5.1.2 Imaging 6 5.1.2.1 Intravenous pyelography 6 5.1.2.2 Ultrasonography 6 5.1.2.3 Computed tomography 6 5.1.2.4 Magnetic resonance ...

Bladder Cancer Page 2 Table of Contents Executive Summary— Bladder Cancer 1 Unmet Clinical Need in Bladder Cancer —2000-2010 3 Unmet Need Rationale— Bladder Cancer 4 Disease Severity 4 Ability of Current Therapies to Reduce Unmet Need 5 Future Gold-Standard Selection. 7 2005 Opportunity Index— Bladder Cancer . 10 Bladder Cancer Patient Population, 2000-2010 12 Sources for Epidemiology Estimates— Bladder Cancer 14 Epidemiology Methodology— Bladder Cancer . 15 General Methodology . 15 United States17 France . 18 Germany 18 Italy. 19 Spain 20 United Kingdom 20 Japan . 21 Percentage Diagnosed. 21 Percentage Drug-Treated . 21 Treatment Decision Tree for Bladder Cancer —United States . 23 Treatment Decision Tree for Bladder Cancer —France. 24 Treatment ...

bladder cancer Bladder Cancer Last Updated: February 8, 2002 Rate this Article Email to a Colleague Synonyms and related keywords: urothelial cancer , transitional cell cancer , transitional cell carcinoma, TCC, bladder cancer , bladder tumor, leiomyosarcoma, rhabdomyosarcoma AUTHOR INFORMATION Section 1 of 11 Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Pictures Bibliography Author: Gary David Steinberg, MD , Director of Urology, Assistant Professor, Department of Surgery, Division of Urology, University of Chicago School of Medicine and Weiss Memorial Hospital Coauthor(s): Hyung ...

1 The Challenge of Bladder Cancer - The Laboratory Can Make a Difference Robert Schlesinger, MD Director, Urology Services Lemuel Shattuck Hospital Massachusetts Dept. of Public Health Diagnostic Products Corporation Bladder Cancer 259,771 new cases/year worldwide 99,059 deaths/year worldwide 5th leading cancer , highest prevalence in Europe, U.S. and Pacific rim nations 3:1 men : women Causes; smoking, high-risk occupations (e.g., textile, leather, rubber & chemical industries) Page 2 2 Bladder Cancer in Europe New cases Deaths Region Male Female Male Female Northern Europe 14,087 5,414 5,459 2,545 Southern Europe 29,305 6,525 9,653 2,379 Western Europe 29,548 8,709 10,591 ...

Leaflet No 8601500 04/03/98 BCa 1 Reviewed 2/03 Information for patients with bladder cancer Urology Department Information prepared by Mrs Sue Cumisky Nurse Practitioner Urology East Somerset NHS Trust (01935) 384394 Further information for people with cancer is available on request or may be obtained by contacting: Macmillan cancer relief 0845 6016161 or CancerBACUP 0800 18 11 99 Page 2 Bladder cancer treatment Information gained from looking at the tumour under the microscope suggests that further treatment is needed. In some cases the cancer has developed deeper roots invading the bladder wall making more radical treatment with surgery or radiotherapy necessary. The treatments are generally equally effective, the aim being to eradicate ...

Abstract. The early detection of carcinoma is very essential for the diagnosis and prognosis of a bladder cancer patient. In this study we have investigated the use of hypericin as a fluorescent tumour marker and laser confocal microscopy as a diagnostic tool to aid the diagnosis of such cancers. Both cellular and clinical studies have been conducted. In the cellular studies, we have compared two bladder cell lines for the uptake and sub-cellular localization of hypericin. It was found that there was a rapid uptake and clearance of hypericin and significant localization in mitochondria and lysosomes. The study also revealed that there was a time- dependent increase in fluorescence intensity in bladder cells. The optimum localization was found to be 2-4 h post drug incubation. In the clinical study, consisting of 30 patients, both white light and fluorescence cystoscopy were performed ...

March 2000, Vol. 29 No. 2 153 Fluorescence Diagnosis of Bladder Cancer after 5-ALA—W Lau et al Cystoscopic Diagnosis of Bladder Cancer by Intravesical Instillation of 5- Aminolevulinic Acid Induced Porphyrin Fluorescence—The Singapore Experience C W S Cheng,* FAMS, MBBS, FRCS (Edin & Glas) , W K O Lau,** MBBS, M Med, FRCS , P H Tan,*** FAMS, MBBS, FRCPA , M Olivo,**** PhD, BSc, BEd Abstract Objectives: 1) To determine whether fluorescence cystoscopy after intravesical administration of 5-aminolevulinic acid (5-ALA) is more sensitive in detection of dysplasia and bladder cancer when compared with conventional cystoscopy. 2) To determine the safety of using 5- ALA. Materials and Methods: A 3% 5-ALA solution was instilled intravesically before cystoscopy in 41 patients. The 5-ALA-induced porphyrin ...